SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Beta Bionics shares slide after pricing underwritten public offering

Beta Bionics priced an underwritten public offering, and the stock fell 5.8% to $18.11 in premarket trading Wednesday after being down 37% for the year at Tuesday’s close.

BBNX

Beta Bionics shares fell after the company priced its underwritten public offering. The stock was down 5.8% to $18.11 in premarket trading on Wednesday. At Tuesday's market close, the shares were down 37% this year. The medical device company said it would offer about 7.7 million shares.

Related stories